Discontinuation report SANDOZ ESOMEPRAZOLE

Last updated on 2022-06-23 History
Report ID 163310
Drug Identification Number 02460939
Brand name SANDOZ ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30GRT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-11-19
Remaining supply date 2020-11-19
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-06-23 French Compare
v1 2022-06-23 English Compare

Showing 1 to 2 of 2